Soedarsono S et al. found that the serum ADA level at the beginning of TB treatment was higher than the level at the end of intensive phase treatment, and then the study concluded that the serum ADA test can be used to evaluate the pulmonary TB treatment response [35]. The gene discussed is ADA; the disease is pulmonary tuberculosis.